From: Becker's Supply Chain Report <>
Subject: Rate of hospital drug spending to slow in 2019 | Feds probe CHS over EHR incentives | Generic approvals hit record high in July | CVS CEO: Don't blame middlemen for high drug prices
View our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+ View our videos on YouTube

August 10, 2018
1. Pharmacy middlemen not to blame for high drug prices, CVS chief says 
2. CHS faces investigation related to EHR incentive program

3. Rate of hospital drug spending to slow in 2019, says Vizient  Full story

4. Looking to expand the reach of your pharmacy services? Learn why telehealth might be the answer during this upcoming webinar.

5. CVS Health 12-hour nasal spray recalled over bacterial contamination  Full story

6. Northwestern lays off 60 IT workers after Epic EHR rollout
7. The rise of specialty pharmacy presents many new opportunities for providers. For insights into overcoming three barriers to entry, download this whitepaper.

8. FDA generic drug approvals hit record high in July  Full story
9. Amazon to open health clinics for Seattle employees
10. Hospital visitor tampered with patient's IV, caused cardiac arrest, officials say  Full story
11. To learn what to do when new technology impedes clinical efficiency, register for this upcoming webinar.

12. Top pharma companies by prescription drug sales  Full story

Contact Us

Editorial Contact: 
Molly Gamble 
(800) 417-2035
Sales, Marketing & Events:
Jessica Cole
President and CEO
Becker's Hospital Review
A Becker's Healthcare Publication
35 E. Wacker Drive, Suite 1782 | Chicago, IL 60601
Becker's Healthcare, 35 E. Wacker, Suite 1782, Chicago, IL 60601
Sent by in collaboration with
Constant Contact